Insider · CIK 0001738340
Samraat S. Raha
cooofficerceopresidentdirector
Files at MYGN (MYRIAD GENETICS INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 31, 2025 | MYGN MYRIAD GENETICS INC | AGrant or award Common Stock | +1,498 | $3.56 | $5,336 | 482,738 | Jun 2, 2025 |
| Apr 30, 2025 | MYGN MYRIAD GENETICS INC | AGrant or award Performance-Based Restricted Stock Unitsderivative | +141,050 | $0.00 | $0 | 141,050 | May 1, 2025 |
| Dec 11, 2024 | MYGN MYRIAD GENETICS INC | FTax withholding Common Stock | -29,578 | $14.51 | $429k | 272,394 | Dec 12, 2024 |
| Nov 30, 2024 | MYGN MYRIAD GENETICS INC | AGrant or award Common Stock | +1,118 | $13.83 | $15k | 301,972 | Dec 2, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.